ASAN FOUNDATION

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1989-06-23

Employees: 501

Market Cap: -

Website: https://ails.amc.seoul.kr

Clinical Trials

Optimal Number of To-and-fro Motion in EUS-guided Fine Needle Aspiration for Pancreatic Masses

Phase 3

Completed

Conditions: Pancreatic Masses

Interventions: Procedure: EUS-FNA
Device: EUS-FNA with suction
Device: EUS-FNA without suction

First Posted Date: 2012-04-12

Last Posted Date: 2014-05-29

Lead Sponsor: Asan Medical Center

Target Recruit Count: 193

Registration Number: NCT01576497

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Pilot Study of Etoposide-based Therapy and Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis

Not Applicable

Terminated

Conditions: Hemophagocytic Lymphohistiocytosis

Interventions: Drug: IST and/or alloHCT

First Posted Date: 2012-03-07

Last Posted Date: 2018-07-20

Lead Sponsor: Asan Medical Center

Target Recruit Count: 12

Registration Number: NCT01547143

Locations: 🇰🇷
Asan Medical center, University of Ulsan College of Medicine, Seoul, Korea, Republic of

Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI

Phase 2

Active, not recruiting

Conditions: Gastrointestinal Stromal Tumors

Interventions: Drug: imatinib

First Posted Date: 2012-03-01

Last Posted Date: 2024-01-02

Lead Sponsor: Asan Medical Center

Target Recruit Count: 23

Registration Number: NCT01541709

Locations: 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of

Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer

Phase 1

Completed

Conditions: Stage IV Gastric Cancer With Metastasis

Interventions: Other: Docetaxel

First Posted Date: 2012-02-03

Last Posted Date: 2015-06-29

Lead Sponsor: Asan Medical Center

Target Recruit Count: 37

Registration Number: NCT01525771

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Second Bowel Preparation for Colonoscopy Failure

Phase 4

Terminated

Conditions: Colonoscopy Failure
Poor Bowel Preparation

Interventions: Drug: polyethylene glycol, Bisacodyl
Drug: polyethylene glycol

First Posted Date: 2012-01-18

Last Posted Date: 2013-02-13

Lead Sponsor: Asan Medical Center

Target Recruit Count: 150

Registration Number: NCT01510977

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

First Line Gefitinib by FDG-PET Metabolic Response

Phase 2

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Gefitinib

First Posted Date: 2012-01-18

Last Posted Date: 2013-01-29

Lead Sponsor: Asan Medical Center

Target Recruit Count: 60

Registration Number: NCT01510990

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors

Phase 1

Conditions: Acute Leukemia
Myelodysplastic Syndrome
Solid Tumors

Interventions: Biological: anti-thymocyte globulin
Biological: filgrastim
Radiation: Total body irradiation
Drug: Fludarabine
Drug: cyclophosphamide
Drug: Tacrolimus
Drug: Mycophenolate mofetil
Drug: Rituximab

First Posted Date: 2012-01-13

Last Posted Date: 2012-01-13

Lead Sponsor: Asan Medical Center

Target Recruit Count: 10

Registration Number: NCT01509300

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Prospective Registry of Patients With Isolated Severe Tricuspid Regurgitation

Completed

Conditions: Tricuspid Regurgitation

First Posted Date: 2011-12-30

Last Posted Date: 2021-02-02

Lead Sponsor: Asan Medical Center

Target Recruit Count: 131

Registration Number: NCT01502462

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity Reserve

Phase 4

Completed

Conditions: Hypertension
Cardiovascular Risk Factors

Interventions: Drug: Rosuvastatin

First Posted Date: 2011-12-13

Last Posted Date: 2014-05-09

Lead Sponsor: Asan Medical Center

Target Recruit Count: 56

Registration Number: NCT01490398

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma

Phase 2

Completed

Conditions: Urothelial Carcinoma

Interventions: Drug: Pemetrexed
Drug: Cisplatin
Drug: Dexamethasone
Drug: Vitamins

First Posted Date: 2011-12-13

Last Posted Date: 2014-09-25

Lead Sponsor: Asan Medical Center

Target Recruit Count: 42

Registration Number: NCT01490437

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy